vs

Side-by-side financial comparison of Paranovus Entertainment Technology Ltd. (PAVS) and RETRACTABLE TECHNOLOGIES INC (RVP). Click either name above to swap in a different company.

Paranovus Entertainment Technology Ltd. is the larger business by last-quarter revenue ($12.4M vs $9.4M, roughly 1.3× RETRACTABLE TECHNOLOGIES INC). Paranovus Entertainment Technology Ltd. runs the higher net margin — -5.5% vs -24.9%, a 19.4% gap on every dollar of revenue. On growth, Paranovus Entertainment Technology Ltd. posted the faster year-over-year revenue change (18033.4% vs 4.0%).

Retractable Technologies Inc is a specialized medical device manufacturer that designs, manufactures and distributes safety-engineered disposable medical products, including retractable syringes, safety needles and IV catheters. Its key customers are healthcare facilities, pharmaceutical companies and public health agencies across North America and global markets, helping reduce needlestick injury risks for medical personnel and patients.

PAVS vs RVP — Head-to-Head

Bigger by revenue
PAVS
PAVS
1.3× larger
PAVS
$12.4M
$9.4M
RVP
Growing faster (revenue YoY)
PAVS
PAVS
+18029.4% gap
PAVS
18033.4%
4.0%
RVP
Higher net margin
PAVS
PAVS
19.4% more per $
PAVS
-5.5%
-24.9%
RVP

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
PAVS
PAVS
RVP
RVP
Revenue
$12.4M
$9.4M
Net Profit
$-681.0K
$-2.3M
Gross Margin
20.0%
-16.2%
Operating Margin
-5.1%
-81.7%
Net Margin
-5.5%
-24.9%
Revenue YoY
18033.4%
4.0%
Net Profit YoY
61.4%
-162.3%
EPS (diluted)
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PAVS
PAVS
RVP
RVP
Q4 25
$9.4M
Q3 25
$12.4M
$10.1M
Q2 25
$10.4M
Q1 25
$8.3M
Q4 24
$9.1M
Q3 24
$10.3M
Q2 24
$6.0M
Q1 24
$7.6M
Net Profit
PAVS
PAVS
RVP
RVP
Q4 25
$-2.3M
Q3 25
$-681.0K
$371.0K
Q2 25
$-87.5K
Q1 25
$-10.5M
Q4 24
$3.8M
Q3 24
$-1.9M
Q2 24
$-14.2M
Q1 24
$429.4K
Gross Margin
PAVS
PAVS
RVP
RVP
Q4 25
-16.2%
Q3 25
20.0%
16.7%
Q2 25
-1.0%
Q1 25
-0.0%
Q4 24
-27.5%
Q3 24
-0.1%
Q2 24
-7.0%
Q1 24
25.0%
Operating Margin
PAVS
PAVS
RVP
RVP
Q4 25
-81.7%
Q3 25
-5.1%
-36.2%
Q2 25
-49.1%
Q1 25
-56.4%
Q4 24
-79.6%
Q3 24
-49.6%
Q2 24
-95.6%
Q1 24
-39.3%
Net Margin
PAVS
PAVS
RVP
RVP
Q4 25
-24.9%
Q3 25
-5.5%
3.7%
Q2 25
-0.8%
Q1 25
-126.6%
Q4 24
41.6%
Q3 24
-18.6%
Q2 24
-234.9%
Q1 24
5.7%
EPS (diluted)
PAVS
PAVS
RVP
RVP
Q4 25
$-0.09
Q3 25
$0.01
Q2 25
$0.00
Q1 25
$-0.35
Q4 24
$0.14
Q3 24
$-0.07
Q2 24
$-0.48
Q1 24
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PAVS
PAVS
RVP
RVP
Cash + ST InvestmentsLiquidity on hand
$5.2M
$2.6M
Total DebtLower is stronger
$895.6K
Stockholders' EquityBook value
$23.6M
$74.4M
Total Assets
$37.3M
$142.6M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PAVS
PAVS
RVP
RVP
Q4 25
$2.6M
Q3 25
$5.2M
$3.4M
Q2 25
$3.0M
Q1 25
$3.4M
Q4 24
$4.2M
Q3 24
$3.9M
Q2 24
$6.9M
Q1 24
$10.0M
Total Debt
PAVS
PAVS
RVP
RVP
Q4 25
$895.6K
Q3 25
Q2 25
Q1 25
Q4 24
$1.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PAVS
PAVS
RVP
RVP
Q4 25
$74.4M
Q3 25
$23.6M
$76.8M
Q2 25
$76.5M
Q1 25
$76.6M
Q4 24
$87.2M
Q3 24
$83.5M
Q2 24
$85.4M
Q1 24
$99.7M
Total Assets
PAVS
PAVS
RVP
RVP
Q4 25
$142.6M
Q3 25
$37.3M
$146.4M
Q2 25
$147.1M
Q1 25
$149.3M
Q4 24
$160.7M
Q3 24
$157.8M
Q2 24
$160.7M
Q1 24
$176.0M
Debt / Equity
PAVS
PAVS
RVP
RVP
Q4 25
0.01×
Q3 25
Q2 25
Q1 25
Q4 24
0.01×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PAVS
PAVS
RVP
RVP
Operating Cash FlowLast quarter
$-159.3K
$-596.5K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PAVS
PAVS
RVP
RVP
Q4 25
$-596.5K
Q3 25
$-159.3K
$-1.3M
Q2 25
$-3.7M
Q1 25
$-1.5M
Q4 24
$-1.1M
Q3 24
$-5.7M
Q2 24
$-2.7M
Q1 24
$-2.0M
Free Cash Flow
PAVS
PAVS
RVP
RVP
Q4 25
Q3 25
$-1.3M
Q2 25
$-4.1M
Q1 25
$-1.6M
Q4 24
$-1.4M
Q3 24
$-6.5M
Q2 24
$-2.8M
Q1 24
$-2.2M
FCF Margin
PAVS
PAVS
RVP
RVP
Q4 25
Q3 25
-13.4%
Q2 25
-38.9%
Q1 25
-18.8%
Q4 24
-15.5%
Q3 24
-63.0%
Q2 24
-46.8%
Q1 24
-29.6%
Capex Intensity
PAVS
PAVS
RVP
RVP
Q4 25
Q3 25
0.9%
Q2 25
3.2%
Q1 25
1.0%
Q4 24
3.3%
Q3 24
7.7%
Q2 24
2.0%
Q1 24
3.0%
Cash Conversion
PAVS
PAVS
RVP
RVP
Q4 25
Q3 25
-3.39×
Q2 25
Q1 25
Q4 24
-0.29×
Q3 24
Q2 24
Q1 24
-4.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons